Fig. 1From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinomaCharacterization of the nanoparticles. a The TEM micrographs of (SFN + TPL)@LCNPs and (SFN + TPL)@CPLCNPs. b The appearance of (SFN + TPL)@LCNPs and (SFN + TPL)@CPLCNPs. c The size distribution and zeta potential of (SFN + TPL)@LCNPs and (SFN + TPL)@CPLCNPs d Protein profiles of 1:platelet, 2:Huh-7 cell, 3:SFN/TPL@PLCNPs, 4:SFN/TPL@CLCNPs, and 5:SFN/TPL@CPLCNPs assessed using SDS-PAGE electrophoresisBack to article page